After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bisepcifics ...

The Chinese manufacturer edges ever-further into Behringer's territory with another enticingly-priced vintage clone ...

For makers of synths and studio technology, however, the emphasis was shifting away from NAMM even before then. Berlin’s ...

The anticipation for another intriguing weekend of matches continues to build. Here's the prediction for all fixtures of the ...

Indian families on H1B and L1 visas, who expected to stay in the U.S. for decades, face the harsh reality of losing their ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Solana network fees and revenue hit new highs amid meme coin hype, but SOL’s price drops 10%. Bullish sentiment could spark a new rally.